標(biāo)題: Titlebook: Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases; Paola Mina-Osorio Book 2017 Springer International P [打印本頁(yè)] 作者: fasten 時(shí)間: 2025-3-21 16:17
書(shū)目名稱(chēng)Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases影響因子(影響力)
書(shū)目名稱(chēng)Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases被引頻次
書(shū)目名稱(chēng)Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases被引頻次學(xué)科排名
書(shū)目名稱(chēng)Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases年度引用
書(shū)目名稱(chēng)Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases年度引用學(xué)科排名
書(shū)目名稱(chēng)Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases讀者反饋
書(shū)目名稱(chēng)Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases讀者反饋學(xué)科排名
作者: mendacity 時(shí)間: 2025-3-21 20:54
1422-7746 The discussed technologies are at different stages in their .As our understanding of immune mediated chronic inflammatory diseases (IMIDs) grows, it becomes more and more clear that these conditions result from the convergence of a multitude of pathogenic mechanisms whose relative individual contrib作者: Biomarker 時(shí)間: 2025-3-22 02:21
Book 2017 the convergence of a multitude of pathogenic mechanisms whose relative individual contribution is different in different patient subsets..Promising new technologies have been conceived that address the hypotheses that targeting multiple pathways simultaneously, selectively delivering therapeutics t作者: 信徒 時(shí)間: 2025-3-22 06:50
Biomarkers in Clinical Trials for Rheumatoid Arthritiszed but can be achievable with good basic and applied research, systematic data collection, and data systems that can be used to integrate and share data. Herein, we explore what is currently known regarding biomarkers for rheumatoid arthritis and discuss issues to be addressed as biomarkers are sought for future development programs.作者: municipality 時(shí)間: 2025-3-22 12:14 作者: 蜈蚣 時(shí)間: 2025-3-22 16:36
Energy Homeostasis of Immune Cells: Translating Cell Bioenergetics into Clinical Application in Rheuw cell bioenergetics constrains and determines the spectrum of immune function, with promising results. However, clinical application of these findings is lagging. The present chapter puts forth a strategy to translate concepts derived from immune cell bioenergetics into clinical use against rheumatoid arthritis.作者: Chromatic 時(shí)間: 2025-3-22 19:19
978-3-319-82538-0Springer International Publishing Switzerland 2017作者: 沉積物 時(shí)間: 2025-3-22 23:54
Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases978-3-319-42252-7Series ISSN 1422-7746 Series E-ISSN 2296-4525 作者: heartburn 時(shí)間: 2025-3-23 01:41
Paola Mina-OsorioThe book describes why certain targets or technologies have not successfully made it into the clinic and what is needed to make that happen.The discussed technologies are at different stages in their 作者: 殺死 時(shí)間: 2025-3-23 08:38 作者: mutineer 時(shí)間: 2025-3-23 10:02 作者: Constitution 時(shí)間: 2025-3-23 17:15
A Tale of Two Worldsand “impure” diagnoses. Neither investigators nor clinicians know whether the same mechanisms apply to both groups or whether the treatment algorithms should be the same. Investigators and clinicians rarely ask: Is there a gold standard for the concept, correct diagnosis? How precise must it be? For作者: 整頓 時(shí)間: 2025-3-23 21:50
The Role of Microparticles as Biomarkers in the Development of Therapy for Autoimmune Disease elevated in the blood of patients with many autoimmune diseases, with flow cytometric assays using antibodies to cell surface markers allowing identification of the cell of origin. In the context of autoimmunity, MPs are important as a source of alarmins or DAMPs (damage-associated molecular patter作者: 缺陷 時(shí)間: 2025-3-23 23:32
Bispecific Antibodiesies of points to consider where bsAbs may require special attention when compared to classical biologics for development. Related to mode of action and target is the selection of the right molecular format. We provide an overview on bsAb formats and then go more specifically over those used in molec作者: Herd-Immunity 時(shí)間: 2025-3-24 03:08
Targeting CD13 with Asn-Gly-Arg (NGR) Peptide-Drug Conjugatessting that the asparagine residue of NGR can rapidly undergo deamidation, a spontaneous reaction that changes NGR to isoDGR (an integrin-binding motif), and the potential biological, pharmacological, and toxicological implications of this sequence transition in peptide-drug conjugates.作者: BARGE 時(shí)間: 2025-3-24 07:05
Stem Cell Therapy in the Treatment of Rheumatic Diseases and Application in the Treatment of Systemicy, as observed in animal models, can be successfully translated in clinical trials. Current understanding, limitations, and future directions for SCT with respect to rheumatic diseases are also discussed.作者: 羊欄 時(shí)間: 2025-3-24 11:06 作者: LUDE 時(shí)間: 2025-3-24 15:15 作者: 摸索 時(shí)間: 2025-3-24 20:46 作者: 值得尊敬 時(shí)間: 2025-3-25 03:10 作者: Brochure 時(shí)間: 2025-3-25 04:50
Patrick S. C. Leung PhD,Zongwen Shuai MD,Bin Liu MD,Shang An Shu PhD,Lingyun Sun MDther tissue transfer techniques are described in detail. The text also covers reconstruction of complex contaminated abdominal wall defects in patients with complex enteric fistulae; ostomies, defects created after the excision of previously placed infected prosthetic mesh, and defects associated with acute tissue l978-1-4614-6354-2作者: 軟弱 時(shí)間: 2025-3-25 09:33 作者: Biofeedback 時(shí)間: 2025-3-25 11:55 作者: 畸形 時(shí)間: 2025-3-25 18:14
Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases作者: depreciate 時(shí)間: 2025-3-25 23:42
e initial years of training to understand and become familiar with the main steps in surgical management while simultaneously providing their senior colleagues with details and technical tips that will help to improve treatment results.978-3-662-52101-4978-3-642-35422-9作者: AUGUR 時(shí)間: 2025-3-26 02:35 作者: 無(wú)能力 時(shí)間: 2025-3-26 07:35 作者: WATER 時(shí)間: 2025-3-26 10:47
Gregory J. Dennis MD,Gonzalo Fernandez MD,Heather Iocca PhD,Holly Hilton PhDe initial years of training to understand and become familiar with the main steps in surgical management while simultaneously providing their senior colleagues with details and technical tips that will help to improve treatment results.978-3-662-52101-4978-3-642-35422-9作者: 藝術(shù) 時(shí)間: 2025-3-26 14:41
Chris Kitsonfer techniques are described in detail. The text also covers reconstruction of complex contaminated abdominal wall defects in patients with complex enteric fistulae; ostomies, defects created after the excision of previously placed infected prosthetic mesh, and defects associated with acute tissue l作者: 牽索 時(shí)間: 2025-3-26 17:29 作者: 全等 時(shí)間: 2025-3-26 21:02 作者: 供過(guò)于求 時(shí)間: 2025-3-27 02:32
Mary-Ellen Costello,Matthew A. Brownfer techniques are described in detail. The text also covers reconstruction of complex contaminated abdominal wall defects in patients with complex enteric fistulae; ostomies, defects created after the excision of previously placed infected prosthetic mesh, and defects associated with acute tissue l作者: PRE 時(shí)間: 2025-3-27 06:05
izes the need for an individualized approach tailored to theThis book covers the entire spectrum of cerebellopontine angle lesions, from the most common to the rarest. All aspects are considered, including biological and radiological characteristics, neurological presentation, diagnosis, treatment o作者: cumber 時(shí)間: 2025-3-27 12:21 作者: 孤獨(dú)無(wú)助 時(shí)間: 2025-3-27 16:50 作者: Synthesize 時(shí)間: 2025-3-27 19:37 作者: 碌碌之人 時(shí)間: 2025-3-28 01:38
Chris Kitson and challenging for surgeons. The lack of high quality evidence leaves surgeons without clear guidance regarding the selection of technique or material to be used when treating these serious problem. .Surgery of Complex Abdominal Wall Defects. has been written to provide this guidance. It covers th作者: flimsy 時(shí)間: 2025-3-28 05:05
respective areas.Complex abdominal wall hernias and complex abdominal wall defects, including stomas or the complications associated with any of the above, are common and challenging for surgeons. The lack of high quality evidence leaves surgeons without clear guidance regarding the selection of te作者: 是貪求 時(shí)間: 2025-3-28 07:15 作者: CRACY 時(shí)間: 2025-3-28 13:36
and challenging for surgeons. The lack of high quality evidence leaves surgeons without clear guidance regarding the selection of technique or material to be used when treating these serious problem. .Surgery of Complex Abdominal Wall Defects. has been written to provide this guidance. It covers th作者: 天文臺(tái) 時(shí)間: 2025-3-28 15:09
Angelo Corti,Martina Fiocchi,Flavio Curnis and challenging for surgeons. The lack of high quality evidence leaves surgeons without clear guidance regarding the selection of technique or material to be used when treating these serious problem. .Surgery of Complex Abdominal Wall Defects. has been written to provide this guidance. It covers th
